MAMBA^® red line – Molecular Profiling of Malignancies (in development)

Precise molecular characterization of tumors is a key component of modern personalized medicine. By detecting somatic mutations, gene fusions or expression markers, qPCR-based assays provide fast, sensitive and cost-efficient diagnostic results for both solid tumors and blood cancers.

These analyses support clinical decision-making, for example in selecting targeted therapies, monitoring disease progression or identifying minimal residual disease.

MAMBA DIAGNOSTIK offers a broad range of ddPCR-based oncology assays for reliable detection of clinically relevant genetic alteraƟons, together with all reagents required for accurate, reproducible and robust molecular tumor profiling.

MUTATIONS

• cancer-associated SNIP mutations